ArticleSchizophrenia (Heidelberg, Germany)2025
Along-tract white matter abnormalities and their clinical associations in recent-onset and chronic schizophrenia.
Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cognitive impairment and associated white matter organization abnormalities across the illness course of schizophrenia.European archives of psychiatry and clinical neuroscience · 2026Article
- Mapping corpus callosum architecture: developmental, genetic, and cognitive correlates in youth.bioRxiv : the preprint server for biology · 2026Article
- Structural White Matter Correlates of the Crowding Effect: Insights From a Tractography Study of the Arcuate Fasciculus Post-Hemispherotomy.Human brain mapping · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Structural impairments in white matter tracts are well-documented in schizophrenia, though their clinical implications remain limited. Most previous studies using diffusion-weighted magnetic resonance imaging (dMRI) and tractography relied on averaged diffusion indices, potentially obscuring localized changes in white matter tracts. Tractometry enables the investigation of localized changes at specific points along white matter tracts. We used dMRI and centerline tractometry to examine along-tract white matter abnormalities in 55 patients with recent-onset schizophrenia, 69 with chronic schizophrenia, and 77 healthy controls. Fractional anisotropy (FA) and peak length were measured at individual points along tract trajectories. Group differences in diffusion indices and their associations with clinical variables, including the Positive and Negative Syndrome Scale (PANSS), were analyzed using linear mixed models and Spearman's rho. In recent-onset schizophrenia, reduced FA was observed in the genu and splenium of the corpus callosum, along with deviations in peak length across multiple white matter tracts. The peak length of association tracts showed a negative correlation with antipsychotic dose. In chronic schizophrenia, widespread reductions in FA and deviations in peak length were identified across various white matter tracts. Decreased FA in commissural tracts was negatively associated with the PANSS negative score, antipsychotic dose, and illness duration. This study identified along-tract white matter abnormalities in recent-onset and chronic schizophrenia and revealed their associations with clinical symptoms. Localized measurements along tract trajectories enhance the detection of clinically relevant abnormalities compared to traditional methods relying on averaged diffusion indices.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.